StreetAlpha
Aktis Oncology, Inc. · SEC Form 4

AKTS Insider Trading

From SEC Form 411 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Aktis Oncology, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $114M bought and $3.2M sold.

← AKTS stock page

Insiders are net buyers
Bought, 12 months$114M6 buys · 6 insiders
Sold, 12 months$3.2M5 sales · 3 insiders
Net+$111Mbought minus sold
Planned sales8%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
Dec2026-01: bought $114MJanFebMarAprMayJun2026-07: sold $3MJulAug2026-09: sold $259KSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when AKTS insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an AKTS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

AKTS cluster buys

All AKTS cluster buys →
  • 6 insiders bought $114MTrades Jan 12, 2026 to Jan 12, 2026 · public Jan 12, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every AKTS insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Sep 23, 2026Akos CzibereChief Medical OfficerSale plan12,500$20.69$259K0Sep 24Form 4
Jul 20, 2026Ken HerrmannDirectorSale4,856$24.56$119K0Jul 21Form 4
Jul 17, 2026Ken HerrmannDirectorSale3,065$25.21$77K0Jul 20Form 4
Jul 8, 2026Akos CzibereChief Medical OfficerSale50,000$27.77$1.4M0Jul 10Form 4
Jul 8, 2026Shulamit Ron-BiggerCOOSale50,000$27.75$1.4M0Jul 10Form 4
Jan 12, 2026Ansbert Gadicke10% ownerBuy1,112,777$18.00$20M10,260,064Jan 14Form 4
Jan 12, 2026Mpm Oncology Innovations Fund LP10% ownerBuy1,112,777$18.00$20M10,260,064Jan 14Form 4
Jan 12, 2026Todd FoleyDirectorBuy232,870$18.00$4.2M4,235,403Jan 14Form 4
Jan 12, 2026Oleg NodelmanDirectorBuy2,222,222$18.00$40M347,305Jan 12Form 4
Jan 12, 2026Helen Susan KimDirectorBuy835,000$18.00$15M157,387Jan 12Form 4
Jan 12, 2026Vida Ventures Ii-a, LLC10% ownerBuy835,000$18.00$15M157,387Jan 12Form 4

AKTS insider trading FAQ

Are AKTS insiders buying or selling?

Insiders are net buyers over the last 12 months. 6 insiders bought $114M of AKTS on the open market in 6 trades, and 3 sold $3.2M in 5 trades, 8% of that under pre-arranged trading plans.

When did an AKTS insider last buy shares?

Ansbert Gadicke (10% owner) bought 1,112,777 shares for $20M on Jan 12, 2026, reported on Jan 14, 2026.

When did an AKTS insider last sell shares?

Akos Czibere (Chief Medical Officer) sold 12,500 shares for $259K on Sep 23, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice